Lung Transplant Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Transplant, including details on risks, prognosis, procedure, surgery, organ donation.

Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.

Glanville AR, Aboyoun CL, Havryk A, Plit M, Rainer S, Malouf MA

The Lung Transplant Unit, St. Vincent's Hospital, Darlinghurst, New South Wales, Australia. aglanville@stvincents.com.au

RATIONALE: Severe and recurrent acute vascular rejection of the pulmonary allograft is an accepted major risk factor for obliterative bronchiolitis. OBJECTIVES: We assessed the role of lymphocytic bronchiolitis as a risk factor for bronchiolitis obliterans syndrome (BOS) and death after lung transplantation. METHODS: Retrospective analysis of 341 90-day survivors of lung transplant performed in 1995-2005 who underwent 1,770 transbronchial lung biopsy procedures. MEASUREMENTS AND MAIN RESULTS: Transbronchial biopsies showed grade B0 (normal) (n = 501), B1 (minimal) (n = 762), B2 (mild) (n = 176), B3 (moderate) (n = 70), B4 (severe) (n = 4) lymphocytic bronchiolitis, and Bx (no bronchiolar tissue) (n = 75). A total of 182 transbronchial biopsies were ungraded (8 inadequate, 142 cytomegalovirus, 32 other diagnoses). Lung transplant recipients were grouped by highest B grade before diagnosis of BOS: B0 (n = 12), B1 (n = 166), B2 (n = 89), and B3-B4 (n = 51). Twenty-three were unclassifiable. Cumulative incidence of BOS and death were dependent on highest B grade (Kaplan-Meier, P < 0.001, log-rank). Multivariable Cox proportional hazards analysis showed significant risks for BOS were highest B grade (relative risk [RR], 1.62; 95% confidence interval [CI], 1.31-2.00) (P < 0.001), longer ischemic time (RR, 1.00; CI, 1.00-1.00) (P < 0.05), and recent year of transplant (RR, 0.93; CI, 0.87-1.00) (P < 0.05), whereas risks for death were BOS as a time-dependent covariable (RR, 19.10; CI, 11.07-32.96) (P < 0.001) and highest B grade (RR, 1.36; CI, 1.07-1.72) (P < 0.05). Acute vascular rejection was not a significant risk factor in either model. CONCLUSIONS: Severity of lymphocytic bronchiolitis is associated with increased risk of BOS and death after lung transplantation independent of acute vascular rejection.

Published 24 April 2008 in Am J Respir Crit Care Med, 177(9): 1033-40.
Full-text of this article is available online (may require subscription).

Articles on Lung Transplant published 1 April 2008:

Preventive effects of curcumin and dexamethasone on lung transplantation-associated lung injury in rats.   Crit Care Med, 36(4): 1205-13.

OBJECTIVE: To investigate potential effects of curcumin or dexamethasone on lung transplantation-associated lung injury. DESIGN: Prospective, randomized, controlled study. SETTING: Research laboratory. SUBJECTS: Adult male Sprague-Dawley rats. INTERVENTIONS: Sham-operated rats were used as time-matched controls. Experimental rats were subjected to unilateral orthotopic lung transplantation with 4 hrs of cold ischemia followed by 2 hrs (or 24 hrs) of reperfusion. Animals were randomly assigned ... [Abstract] [Full-text]

Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection.   Eur Respir J, 31(4): 707-13.

Acid gastro-oesophageal reflux (GOR) and gastric aspiration have been labelled as risk factors for chronic rejection bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx). The present study aimed to further characterise GOR (both acid and nonacid) and the degree of gastric aspiration in LTx recipients both with and without BOS. Impedance-pH recordings were used for GOR detection. Pepsin and bile acid levels were measured in bronchoalveolar lavage fluid (BALF). A total of 48% ... [Abstract] [Full-text]

Articles on Lung Transplant published 31 March 2008:

Extracorporeal membrane oxygenation as a bridge to emergency heart-lung transplantation in a patient with idiopathic pulmonary arterial hypertension.   J Heart Lung Transplant, 27(4): 466-8.

Lung transplantation with or without cardiac transplantation offers the only hope of long-term, symptom-free survival for patients with advanced idiopathic pulmonary arterial hypertension. We describe a patient who underwent an emergency pulmonary embolectomy. During surgery, it was discovered that the patient had idiopathic pulmonary arterial hypertension. After the patient was weaned from cardiopulmonary bypass, pulmonary hypertension caused right-sided heart failure, and a right ventricular ... [Abstract] [Full-text]

Regression of pulmonary lymphangioleiomyomatosis (PLAM)-associated retroperitoneal angiomyolipoma post-lung transplantation with rapamycin treatment.   J Heart Lung Transplant, 27(4): 462-5.

Pulmonary lymphangioleiomyomatosis (PLAM) is an indication for lung transplantation (LTx). Angiomyolipomas occur in approximately 50% to 60% of patients with PLAM. We describe a patient presenting with hemoptysis post-LTx for PLAM. Computed tomography (CT) scan demonstrated no pulmonary abnormality, but identified a retroperitoneal mass confirmed as angiomyolipoma by CT-guided core biopsy. Based on experimental work that rapamycin may inhibit angiomyolipoma cells, we commenced the patient on ... [Abstract] [Full-text]

Native lung volume reduction surgery relieves functional graft compression after single-lung transplantation for chronic obstructive pulmonary disease.   J Thorac Cardiovasc Surg, 135(4): 931-7.

OBJECTIVE: Single-lung transplantation is an accepted treatment for end-stage lung disease caused by chronic obstructive pulmonary disease. A complication unique to single-lung transplantation for chronic obstructive pulmonary disease is graft dysfunction due to compression caused by native lung hyperinflation. We hypothesized that patients with functional compromise from native lung hyperinflation would benefit from native lung volume reduction surgery. METHODS: The charts of all patients ... [Abstract] [Full-text]

Articles on Lung Transplant published 27 March 2008:

Effect of multiorgan donation after cardiac death retrieval on lung performance.   ANZ J Surg, 78(4): 262-5.

AIM: For donation after cardiac death (DCD) transplantation to achieve its full potential, multiorgan retrieval is desirable. Although there are several novel individual techniques recently described for DCD lung donation, they have not been evaluated or compared in a DCD multiorgan scenario. DESCRIPTION: This study describes (i) the technical aspects and (ii) early lung and abdominal organ performance of several combinations of DCD donor liver, kidney and lung retrieval techniques that would ... [Abstract] [Full-text]

Articles on Lung Transplant published 21 March 2008:

Spirometry after transplantation: how much better are two lungs than one?   Ann Thorac Surg, 85(4): 1193-201, 1201.e1-2.

BACKGROUND: The purpose of this study was to determine how much double lung transplantation improves lung function over single lung transplantation and to identify predictors of lung function after transplantation. METHODS: From February 1990 to November 2005, 463 adults underwent lung transplantation. Among 379 of these patients (82%), 6372 evaluations of postoperative normalized forced expiratory volume in 1 second (FEV(1)) and forced vital capacity (FVC) were analyzed using longitudinal ... [Abstract] [Full-text]

Articles on Lung Transplant published 14 March 2008:

Fast track recovery following en bloc heart-lung-liver transplantation in a patient with cystic fibrosis complicated by severe portal hypertension.   Heart Lung Circ, 17(2): 154-6.

A 36-year-old man with cystic fibrosis and severe portal hypertension underwent en bloc heart-double lung-liver transplantation. An early extubation with an aggressive physiotherapy made an early ambulation feasible and contributed to an early discharge from the hospital. [Abstract] [Full-text]

© 2005-2008 Lung Transplant Research Today. All Rights Reserved.